Front. Bioeng. Biotechnol. Frontiers in Bioengineering and Biotechnology Front. Bioeng. Biotechnol. 2296-4185 Frontiers Media S.A. 744657 10.3389/fbioe.2021.744657 Bioengineering and Biotechnology Systematic Review Micelles Based on Lysine, Histidine, or Arginine: Designing Structures for Enhanced Drug Delivery Xie et al. Micelles Containing Basic Amino Acids Xie Li Liu Rong * Chen Xin He Mei Zhang Yi Chen Shuyi School of Medicine and Nursing, Chengdu University, Chengdu, China

Edited by: Bin He, Sichuan University, China

Reviewed by: Xianglong Hu, South China Normal University, China

Aristeidis Papagiannopoulos, Theoretical and Physical Chemistry Institute, National Hellenic Research Foundation, Greece

 *Correspondence: Rong Liu, liurongscu@126.com

This article was submitted to Biomaterials, a section of the journal Frontiers in Bioengineering and Biotechnology

 27 09 2021 2021 9 744657 20 07 2021 30 08 2021 Copyright © 2021 Xie, Liu, Chen, He, Zhang and Chen. 2021 Xie, Liu, Chen, He, Zhang and Chen

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Natural amino acids and their derivatives are excellent building blocks of polymers for various biomedical applications owing to the non-toxicity, biocompatibility, and ease of multifunctionalization. In the present review, we summarized the common approaches to designing and constructing functional polymeric micelles based on basic amino acids including lysine, histidine, and arginine and highlighted their applications as drug carriers for cancer therapy. Different polypeptide architectures including linear polypeptides and dendrimers were developed for efficient drug loading and delivery. Besides, polylysine- and polyhistidine-based micelles could enable pH-responsive drug release, and polyarginine can realize enhanced membrane penetration and gas therapy by generating metabolites of nitric oxide (NO). It is worth mentioning that according to the structural or functional characteristics of basic amino acids and their derivatives, key points for designing functional micelles with excellent drug delivery efficiency are importantly elaborated in order to pave the way for exploring micelles based on basic amino acids.

 micelles lysine histidine arginine basic amino acids drug delivery Introduction

In the past few decades, micelles, as an effective drug delivery system, have considerably attracted worldwide attention for the treatment of tumors. As drug carriers, micelles have many advantages, such as easily synthesizing and modifying chemical structures, nanoparticulate size, enhanced water solubility of drug, prolonged circulation time, increased accumulation in tumor sites, reduced side effects of drugs, as well as improved drug bioavailability and efficiency (Kim et al., 2008; Sun et al., 2009; Aw et al., 2011; Wang et al., 2011). However, up to now, only a few micellar products have been approved by the Food and Drug Administration (FDA) (Cabral and Kataoka, 2014; Deshmukh et al., 2017; Adityan et al., 2020). One possible reason is their potential toxicity (Gupta et al., 2015; Knudsen et al., 2015; Deshmukh et al., 2017). Thus, natural or synthetic biodegradable materials are utilized for constructing micelles to solve the problem (Deng et al., 2012; Grossen et al., 2017; George et al., 2019).

Amino acids are a class of small-molecule compounds that are widespread in nature. More than 300 natural amino acids have been found, but only 20 amino acids take part in the human protein synthesis (Canfield and Bradshaw, 2019; Kelly and Pearce, 2020). Most of the 20 amino acids are good raw materials for fabricating micelles, for example, lysine (Itaka et al., 2003; Cheng et al., 2021; Kanto et al., 2021), arginine (Yao et al., 2016; Jiao et al., 2019), histidine (Guan et al., 2019; Wang Z. et al., 2019), glutamic acid (Krivitsky et al., 2018; Ma et al., 2020; Brunato et al., 2021), aspartic acid (Yeh et al., 2013; Teng et al., 2017), cysteine (Xu W. et al., 2015). Among them, there are three basic amino acids namely, lysine, histidine, and arginine, whose side chains contain amino, imidazolyl, and guanidine groups, respectively. The three basic groups can be protonated in acidic condition to play some special roles in the construction of micelles. For example, amino groups in the lysine side chain can be applied as a chemical attachment site, which facilitates the construction of micelles (Liu et al., 2015). The imidazolyl group of histidine has the characteristics of protonation and deprotonation, making histidine-based micelles pH-responsive (Augustine et al., 2020a). Guanidine group of arginine is positively charged after protonation and contributes to the membrane-penetration ability of micelles (Geihe et al., 2012; Hu et al., 2015). In addition, poly(amino acids) synthesized by the above three basic amino acids have good biocompatibility and biodegradability. Moreover, poly(amino acids) contain many chemically modifiable side groups, providing abundant active groups for constructing functional micelles (Xu H. et al., 2015; Augustine et al., 2020b). Therefore, basic amino acids have a broad application in the field of drug delivery.

This review describes the design and construction of drug-loaded micelles based on the three basic amino acids or their derivatives from the following perspectives: 1) Design of micelles based on the position and role of lysine in the micelle skeleton. 2) Construction of micelles based on the pH-sensitive properties of histidine. 3) Introduction of micelles using arginine’s cell-membrane-penetrating activity, and antitumor ability to convert to NO.

 Lysine-Based Micelles Lysine-Based Linkers

Lysine, lysine-based dendrimer, or polylysine may serve as a linker in micelles. Compared with a single lysine molecule as a linker, the lysine-based dendrimer and polylysine possess more abundant active groups.

A Single Lysine Molecule as Linker

Lysine contains two amino groups and one carboxylic group. Therefore, when lysine is adopted as a linker during the construction of micelles, it can react with drugs, compounds, or polymeric materials containing active groups.

There are two methods of linking lysine and the above materials: 1) two amino groups of lysine are utilized to connect materials with carboxylic groups. For example, two amino groups of lysine are separately connected with carboxyl group of hydrophobic stearic acid and the terminal carboxyl group of hydrophilic polyglutamic acid to obtain amphiphilic diblock micelle skeleton (Chang et al., 2017); 2) amino group and carboxyl group of lysine are linked to hydrophilic or hydrophobic materials with carboxyl group or amino group. For example, Wang et al. (2012) connected carboxyl group of lysine with hydroxyl group of hydrophilic polyethylene glycol by an ester bond and connected two amino groups of lysine with two vitamin E succinate molecules as hydrophobic anticancer drug to construct a drug-loaded micelle skeleton.

 Lysine-Based Dendrimer as Linker

Compared with lysine, lysine-based dendrimer as linker contains more active functional groups, which can provide more conjugation sites for micelles construction (Xiao et al., 2009; Li et al., 2011; Guo et al., 2020). For example, the third-generation lysine dendrimer has one carboxyl group and eight amino groups. In Figure 1A (Xiao et al., 2009), Kit S Lam group built the hydrophilic part of micelles by condensation of carboxyl group of generation 3 (G3) lysine dendrimer and amino groups of monomethyl-terminated polyethylene glycol monoamine with a molecular weight of 5,000 Da (PEG5k). Subsequently, eight cholic acid molecules (CA) were connected to the terminal amino groups of G3 lysine dendrimer through an ester bond to construct amphiphilic block polymer (PEG5k-CA8). Finally, PEG5k-CA8 was self-assembled into micelles, which significantly increased the paclitaxel loading capacity and fulfilled enhanced in vivo drug delivery. Three years later, the same research group made a cross-linked micelle based on PEG5k-CA8 (Figure 1B; Li et al., 2011). Unlike PEG5k-CA8, four amino groups of the G3 lysine dendrimer were firstly connected with cysteine (Cys), and then, eight cholic acid molecules were introduced to construct PEG5k-Cys4-L8-CA8 micelle. Finally, thiol groups in the cysteine were oxidated to form cross-linked micelles, resulting in the improvement of micellar stability.

(A) The chemical structure of PEG5k-CA8 G3 lysine dendrimer (Xiao et al., 2009). (B) Schematic representation of the disulfide cross-linked micelles formed by the oxidization of thiolated PEG5k-Cys4-L8-CA8 after self-assemble (Li et al., 2011). Abbreviation: PEG, polyethylene glycol; CA, cholic acid; Cys, cysteine; L, lysine.

 Poly(L-lysine) as Linker

Poly(L-lysine) has abundant side chain amino groups (Li et al., 2020), which provides many chemical active sites to connect hydrophilic and hydrophobic segments. Therefore, poly(L-lysine) as linker has several advantages over constructing drug or gene delivery vehicle.

Firstly, the side chain amino groups located in poly(L-lysine) interact with drugs, siRNA, or other substances through physical interactions to achieve desired loading of micelle, including electrostatic interactions and hydrophobic interactions. For example, Lintao Cai group designed an amphiphilic triblock copolymer poly(ethylene glycol)-b-poly(L-lysine)-b-poly(L-leucine) (PEG-PLL-PLLeu) to load ovalbumin (OVA) by electrostatic interactions between the side chain amino groups of polylysine and ovalbumin vaccine (Figure 2A; Luo et al., 2013). Using the same triblock polymer, the research team also used the polyleucine block as the hydrophobic core to incorporate docetaxel by the hydrophobic interactions, while the side chain amino groups of polylysine were used to load siRNA by electrostatic interaction to achieve co-loading of anticancer drug and gene (Figure 2B; Zheng et al., 2013).

Schematic illustration of PEG-PLL-PLLeu micelles loaded with OVA (A) (Luo et al., 2013) or siRNA and drug (B) (Zheng et al., 2013). Abbreviation: PEG, poly(ethylene glycol); PLL, poly(L-lysine); PLLeu, poly(L-leucine); OVA, ovalbumin.

Secondly, covalently cross-linked polylysine linker could be constructed by the addition of disulfide cross-linker to realize the improvement of micellar stability. To take an example, Koo et al. prepared a triblock polymer, poly (ethylene glycol)-b-poly(L-lysine)-b-poly(L-phenylalanine) (PEG-PLys-PPhe) (Koo et al., 2008; Koo et al., 2012), which self-assembled into micelles. Then, the side chain amino groups of polylysine linker were reacted with 3,3′-dithiobis (sulfosuccinimidylpropionate) cross-linkers to realize micellar cross-linking (Figure 3; Koo et al., 2012). For the cross-linked micelles, there was no change in the particle size and spherical morphology. The stability of micelles in solution was investigated by detecting the scattering light intensity. The non-cross-linked and cross-linked micelles were separately incubated in PBS with 50% serum for 30 min, and the scattered light intensity of the former decreased to 49% of the initial intensity, while that of the latter dropped about 5%. Even if the incubation time of the latter was prolonged to 2 h, 85% of the initial intensity was still maintained. In addition, the non-cross-linked and cross-linked micelles were also incubated with a 2.5 g/L SDS solution. At 2 h, the scattering light intensity of the non-cross-linked micelles decreased to 50%, while that of the cross-linked micelles still reached more than 90% of the initial scattering intensity. The above results suggested that micellar stability was improved by cross-linking of polylysine linker. More importantly, disulfide bonds in cross-linked micelles are redox-sensitive, which can be cleaved by glutathione (GSH) (Zhang et al., 2016; Kang et al., 2018). In the blood circulation and cells, there are different concentrations of GSH (Jones et al., 1998; Kang et al., 2018), which directly affected the degree of disulfide bond cleavage in polylysine linker. For example, in the blood circulation, GSH concentration is low (∼2 μM) (Jones et al., 1998), and the degree of disulfide bond breakage is low, resulting in slow drug release in blood. Conversely, the concentration of GSH in most cancer cells is high (∼10 mM) (Kim et al., 2021), the disulfide bond in polylysine linker is broken to a high degree, and the barrier for drug release is caused by the layer of polylysine linker is removed, resulting in faster drug release. Therefore, cross-linked micelles by 3,3′-dithiobis (sulfosuccinimidylpropionate) cross-linkers were beneficial to reduce the loss of encapsulated drugs in the blood circulation and achieve responsive drug release in the target cells.

Illustration of shell cross-linking of DTX-loaded micelles with redox-labile disulfide cross-links and triggered release of DTX by intracellular GSH (Koo et al., 2012). Abbreviation: GSH, glutathione; DTSSP, 3,3′-Dithiobis (sulfosuccinimidylpropionate); DTX, docetaxel.

 Poly(L-lysine) as the Core of Micelles

Poly(L-lysine) is positively charged and water-soluble, containing a lot of amino groups. Theoretically, poly(L-lysine) is difficult to form the core of micelles because of the poor hydrophobicity. However, there are several ways to assist polylysine in constructing the micellar core. First of all, based on electrostatic interaction, polylysine reacts with oppositely charged polyelectrolytes or molecules to significantly reduce its water solubility, so that polylysine can be used to construct the core of micelles (Boudier et al., 2009; Mebarek et al., 2013). In the next place, amino groups of polylysine are chemically modified to enhance the nucleation force of micellar core. In the following sections, the above two ways will be presented separately.

Construction of Micellar Core Through Electrostatic Interaction

The positively charged polylysine and negatively charged polymers can facilely form micellar core by electrostatic interaction. Taking polylysine and polymethacrylic acid-b-polyethylene oxide as an example, amino group of polylysine and carboxyl group of polymethacrylic acid block were combined by electrostatic interaction, and then, peptide drugs were wrapped to give a stable ternary composite micelle with a particle size of 82 nm (Boudier et al., 2011). The micelle not only kept stable under physiological pH conditions (pH = 7.4) but also facilitated the delivery of peptide drugs. After being endocytosed, the side chain amino group of polylysine was protonated under the acidic condition of cell endosomes (pH = 5), which would disintegrate the micellar core and release peptide drugs.

Alternatively, the terminal group of polylysine is connected with a hydrophilic chain segment, such as polyethylene glycol to form hydrophilic block polymer, which is chosen as positively charged polymer to build the core of the micelle through electrostatic interaction with other hydrophilic block polymers with opposite charge (Xu H. et al., 2015). It has been reported that the influence of the length of positively charged chain of pol(ethylene glycol)-b-poly(L-lysine) and negatively charged chain of poly(ethylene glycol)-b-poly(α, β-aspartic acid) on the self assembly of polyion complex micelles. When the lengths of poly(L-lysine) and poly(α, β-aspartic acid) segments with opposite charge differed greatly, the complex formed by poly (ethylene glycol)-b-poly(L-lysine) and poly(ethylene glycol)-b-poly(α, β-aspartic acid) was unstable and micelles could not form. For example, there were 18 repeating units of polylysine segment and 78 repeating units of polyaspartic acid segment, or 78 repeating units of polylysine segment and 18 repeating units of polyaspartic acid segment. On the contrary, if there was a small difference in the chain length of poly(L-lysine) and poly(α, β-aspartic acid) segments, micelles with charge would be constructed. While the dissociation degree of carboxyl group and amino group in polymer was easily affected by environmental acidity, resulting pH-dependent charge-reversal micelle was fabricated (Lv et al., 2014). Lv et al. (2014) employed MPEG-NH2 as initiator and prepared cationic block copolymer containing lysine and phenylalanine, methoxy poly (ethylene glycol)-b-poly(L-lysine-co-L-phenylalanine), by NCA ring-opening polymerization. In the same way, they also prepared anionic block polymer containing glutamic acid and phenylalanine, methoxy poly(ethylene glycol)-b-poly(L-glutamic acid-co-L-phenylalanine). In two block copolymers, the molar ratio of lysine and L-glutamic acid residues was 1:1.1, that is, lysine repeating unit in cationic block polymer was one less than glutamic acid repeating unit in the anionic block polymer. When methoxy poly(ethylene glycol)-b-poly(L-lysine-co-L-phenylalanine) and methoxy poly(ethylene glycol)-b-poly(L-glutamic acid-co-L-phenylalanine) were electrostatically combined to form micelle, due to the presence of free carboxyl residue of glutamic acid, the surface of micelle was negatively charged at physiological pH (pH 7.4). However, in acidic tumor microenvironment, the dissociation degree of carboxyl group decreased, while that of amino group increased. Consequently, the surface charge of micelles reversed from negative to positive, which was not only beneficial for micellar stability under physiological pH but also for their endocytosis after reaching cancer cells, as shown in Figure 4.

Schematic illustration of charge-conversional behavior and endocytosis performance of polyion complex micelles (Lv et al., 2014).

Besides adding hydrophilic block polymers with negative charge, some negatively charged photosensitizers, drugs, or genes can also interact with hydrophilic block polymer containing polylysine to form micellar core through electrostatic interactions (Jang et al., 2006; Osada et al., 2010; Dirisala et al., 2014; Lu et al., 2020; Zheng et al., 2020). Positively charged polylysine segments were complexed with negatively charged photosensitizers, genes, or drugs to make them become a part of the micellar core. The encapsulated photosensitizers, genes, or drugs could avoid enzyme degradation or removal by the reticuloendothelial system (Beyermann and Kukula, 2000; Harada-Shiba et al., 2002; Osada et al., 2012), thereby improving the therapeutic effect (Sugisaki et al., 2008; Nishiyama et al., 2009). For example, when poly(ethylene glycol)-block-poly(L-lysine) (PEG-PLys) was electrostatically compounded with plasmid DNA (pDNA), pDNA was folded by PEG-PLys to form a hydrophobic rod-like core (Osada et al., 2010). The length of the rod-like core was affected by the length of polylysine segment. The longer the polylysine segment was, the more conducive the DNA was compressed. Moreover, with increasing the length of polylysine, the length distribution of the formed micellar core became narrower, which was favorable for endocytosis (Dirisala et al., 2014).

 Enhancing the Nucleation Force of Micelles Through Chemically Modifying Amino Groups of Polylysine to Construct Micellar Core

Sulfhydryl groups, carboxyl groups, or hydrophobic molecules are introduced to the side chain amino groups of polylysine segment by chemical method, which improves the nucleation force of micelles containing polylysine segment.

 Cross-Linking the Micellar Core by Introducing Sulfhydryl Groups

When sulfhydryl groups are introduced into hydrophilic block polymer with polylysine segment, under oxidation condition, sulfhydryl groups are oxidized to form disulfide bond, thereby cross-linking polylysine segment and forming core cross-linked micelle (Miyata et al., 2004; Vachutinsky et al., 2011; Oe et al., 2014; Takeda et al., 2017). Core cross-linked micelles show enhanced resistance to the shear stress of blood circulation. Takeda et al. (2017) integrated 1-imino-4-mercaptobutyl (IM) groups as cross-linking agent into the side chain amino groups of polylysine segment in poly (ethylene glycol)-b-poly(L-lysine) (PEG-PLys). Introduction rate of IM accounted for 49% of lysine residues of polylysine segment. Under oxidation condition, PEG-PLys (IM) and pDNA were compounded to form core cross-linked polyplex micelle at the N/P ratio of 2:0, which was defined as a residual molar ratio of amino groups in PEG-PLys to phosphate groups in pDNA. In this process, it was accompanied by disulfide bond cross-linking and a combination of positive and negative charges. When core cross-linked micelles were exposed to venular blood flow (30 dyne/cm2 shear stress) for 30 min, they could remain stable, and the size of the rod-shaped core was not affected. In contrast, non-cross-linked micelles showed a size increase, from 194 to 242 nm, and pDNA degradation up to 50% under the same condition. Even if shear stress reached 100 dyne/cm2, the particle size of core cross-linked micelles was still maintained unchanged. Maintenance of the particle size was not only beneficial for micelles to enter cells and protect pDNA from degradation by DNasel but also significantly prolonged residence time of pDNA in mice and improved gene transfection efficiency in vivo.

 Charge Reversal of Polylysine by Introducing Carboxyl Groups

If carboxyl groups are introduced into polylysine, its electrical property will vary from positive to negative charge. Thus, polylysine with negative charge can be combined with drugs with positive charge, such as doxorubicin with one amino group, to realize the load of positively charged drugs. For example, the ring-opening polymerization of cis-cyclohexene-1,2-dicarboxylic anhydride (CDA) was initiated from the side chain amino groups of methoxy poly(ethylene glycol)-block-poly(L-lysine) (mPEG-b-PLL) to get anionic methoxy poly(ethylene glycol)-block-poly(N(ε)-((1-carboxyl-cis-cyclohexene)-2-carbonyl)-L-lysine (mPEG-b-PCLL) with acid-degradable side amide bond, which was shown in Figure 5 (Wang J. et al., 2015). The carboxyl-functionalized polylysine segment of mPEG-b-PCLL interacted with doxorubicin to form micellar core. In acidic extracellular microenvironment of tumor cells (pH = 6.8), the volume of micelles expanded, resulting in rapid release of drug. When micelles entered more acidic endo/lysosomes (pH = 5.5), the cumulative release rate of drug was over 75% at 72 h. This might be related to the cleavage of the side amide bond of mPEGpolypeptide copolymer, leading to the disassembly of the micellar core (Chen et al., 2015).

Schematic illustration of the preparation of pH-responsive PIC micelle, and its circulation in vivo, accumulation in tumor tissue, and finally, pH-triggered intracellular DOX release after intravenous injection (Wang J. et al., 2015). Abbreviation: PEG, poly(ethylene glycol); PLL, poly(L-lysine); CDA, cis-cyclohexene-1,2-dicarboxylic anhydride; PCLL, poly(N(ε)-((1-carboxy-cis-cyclohexene)-2-carbonyl)-L-lysine; DOX, doxorubicin; PIC micelle, polyion complex micelle.

 Hydrophobic Modification of Polylysine by Introducing Hydrophobic Molecules

After introducing hydrophobic molecules into the side chain amino groups of polylysine, the solubility of polylysine was changed from hydrophilic to hydrophobic. The modified hydrophobic polylysine could directly construct the core of micelles and wrap hydrophobic drugs (Wen et al., 2011; Ding et al., 2013; Lin et al., 2014). For instance, ε-carbobenzyloxy-L-lysine N-carboxyanhydride (Lys(Z)-NCA) was first synthesized by using N-ε-carbobenzyloxy-L-lysine as starting material. Then, it was reacted with propargylamine through ring-opening polymerization to produce hydrophobic α-alkyne-poly-(N-ε-carbobenzyloxy-L-lysine) (α-alkyne-PZLL). Next, α-alkyne-PZLL was added to further link with dendritic polyamidoamine (PAMAM) block copolymer (N3-D3) to synthesize amphiphilic PZLL-block-dendritic PAMAM copolymers (PZLL-D3) by copper-catalyzed azidealkyne cyclization (Lin et al., 2014). PZLL-D3 micelles enabled co-loading of doxorubicin and gene, where the PZLL core loaded doxorubicin through hydrophobic interactions, and the PAMAM shell carried gene through electrostatic interactions.

If nitro group was also introduced into the para-position of benzene ring of poly-(N-ε-carbobenzyloxy-L-lysine) segment of micelle, it would make micelle sensitive to hypoxia, which was more conducive to the rapid drug release of micelle in the hypoxic tumor tissue (Thambi et al., 2016). The case in point was the two-layered biodegradable micelle prepared by self-assembly of poly(ethylene glycol)-b-poly(ε-(4-nitro)benzyloxycarbonyl-L-lysine) (PEG-b-PLys-g-NBCF) diblock copolymers (Figure 6A). Under the hypoxic environment, the nitro groups on NBCF were easily reduced to produce amine groups by a series of six electron-transfer reactions in the presence of cellular nucleophiles or nitroreductases. As a consequence, the formed amine groups continued to induce the degradation of the N-(4-aminobenzyloxycarbonyl)-based derivative into small molecular compounds. Owing to the loss of hydrophobic NBCF groups in the polylysine segment of micelle, the micellar core disintegrated and drug was rapidly released (Figure 6B).

Synthetic route for preparation (A) and mechanism of hypoxic reduction under the nitroreductase of the hypoxia-sensitive copolymer (B) (Thambi et al., 2016). Abbreviation: PEG, poly(ethylene glycol); PLys, poly(L-lysine); DIPEA, N,N-diisopropylethylamine.

 Polylysine as Micellar Shell

When polylysine is connected to hydrophobic block, polylysine will act as the shell of micelle so that the surface of micelle is positively charged. However, it is generally known that cationic nanocarriers interact strongly with serum components, causing severe aggregation and rapid clearance by the reticuloendothelial system (RES) (Oupicky et al., 2002; Zhang et al., 2020), which results in their short half-life in the blood circulation.

Researchers have made some efforts to address the above issues. A good strategy is to shield positive charge of micelles by occupying amino groups of polylysine. Song et al. (2013) cross-linked polylysine chains in the micellar shell by introducing cisplatin (IV) prodrug as a bi-functional cross-linker to reduce the number of free amino groups. As a result, the amount of positive charge on the surface of micelles was reduced. As shown in Figure 7, monomethoxyl poly(ethylene glycol)-b-poly(ε-caprolactone)-b-poly(L-lysine) (MPEG-b-PCL-b-PLL) block copolymer self-assembled into micelle, whose shell was composed of MPEG and PLL segments. Thereafter, PLL segment was cross-linked by cisplatin (IV) prodrug, and amino groups of PLL segment were occupied, which reduced the surface positive charge of micelles. Moreover, the larger the proportion of cross-linked amino groups was, the lower the positive charge of micelles was. The most important thing to note from Figure 7 was the triggered release of cisplatin (IV) prodrug from the cross-linked micellar shell under acidic condition or in the presence of mild reducing agents. At pH 5.0, the release rate of platinum was significantly higher than that at pH 7.4. Under the condition of 5 mM sodium ascorbate, cisplatin (II) was directly released. The released cisplatin (II) could be chelated by DNA nucleobases of tumor cells, which led to the cross-linking between adjacent nucleobases, along with preventing DNA replication, transcription, and cell division (Boulikas et al., 2007; Khoury et al., 2020).

Preparation of MPEG-b-PCL-b-PLL/cisPt (IV) micelles and the proposed pathway of action (Song et al., 2013). Abbreviation: PLys, poly(L-lysine); PLLA, poly(L-lactide); PIC, polyion complex.

Another example was shown in Figure 8 (Ohya et al., 2010). Anionic hyaluronic acid (HA) was coated on the outer layer of poly(L-lysine)-b-poly(L-lactide) (PLys-b-PLLA) block copolymer micelles by electrostatic interactions. Because amino groups of polylysine were covered by HA, the HA-coated polylysine micelles possessed extremely high resistance to dilution and colloidal stability, whose apparent CMC was 2.1 × 10−11 mg/ml and hydration particle size remained stable in PBS solution containing 10% FBS for 24 h. In the follow-up study (Ohya et al., 2011), the polyanion micelle was used for drug delivery. HA not only improved the stability of micelles and prolonged circulation time in the blood but also controlled drug release rate and reduced the cytotoxicity of HA-coated polylysine micelles.

Schematic illustration for the preparation of HA-coated micelles (Ohya et al., 2010). Abbreviation: HA, hyaluronic acid; PLys, poly(L-lysine); PLLA, poly(L-lactide).

“Constructing charge-reversal polylysine segment” is another strategy to solve the problem of cationic micelles-based polylysine. The micelles based on charge-reversal polylysine are negatively charged in the blood circulation and will complete positive-surface conversion after reaching tumor tissue or cells (Du et al., 2010; Zhang et al., 2020), which is beneficial to improve the phagocytosis of tumor cells (Du et al., 2010; Pittella et al., 2011). Guan et al. (2017) synthesized folate-poly(L-lysine)-poly(lactic acid) (FA-PLL-PLA), and then, citric acid (CA) was introduced into the side chain amino groups of polylysine by amide bond to complete the construction of a target copolymer, FA-PLL(CA)-PLA. FA-PLL(CA)-PLA could self-assemble to form micelles, whose surface charge was −19.1 mV at pH 7.4. Under the acid environment (pH = 6.5), the micelles were positive in charge (+15.5 mV). Furthermore, the positive charge rapidly increased as the pH value decreased (Figure 9). The negative-to-positive charge reversal of micelles is due to break of the amide bond between CA and the side chain amino groups of polylysine segment under the acidic condition. The design of charge-reversal polylysine segment could mask the positive charge of micelles in the blood circulation and expose the positive charge in the tumor tissue or cells, which is beneficial to keep the micellar stability under physiological pH and increase the binding opportunities of the micelles with negatively charged tumor cell membrane in the acidic tumor microenvironment.

Illustration of the folate-conjugated pH-responsive polymeric micelles based on FA–PLL(CA)–PLA for receptor-mediated endocytosis and pH-triggered release (Guan et al., 2017). Abbreviation: FA, folate; PLL, poly(L-lysine); CA, citric acid; PLA, poly(lactc acid); DOX, doxorubicin.

 Histidine-Based Micelles

Extracellular pH of most solid tumors is about 5.8–7.2 (Lee et al., 2008), which is mainly due to lactic acid derived from anaerobic glycolysis and carbonic acid formed from carbon dioxide and water by carbonic anhydrase over-expressed in tumor (Fukumura and Jain, 2007; Lee et al., 2008). Materials protonated in this pH range are suitable for building pH-sensitive drug-delivery systems to target tumor. Histidine is an excellent candidate, whose pKa value is about 6.0. Moreover, histidine is the only amino acid containing imidazole ring among 20 natural amino acids, which has an electron lone pair on the unsaturated nitrogen, resulting in the amphoteric formation of histidine by protonationdeprotonation (Wu et al., 2013). In the weak acid environment, the imidazole ring undergoes protonation, which making transform of histidine from hydrophobic to hydrophilic, resulting in the increasing solubility of histidine (Liu et al., 2012b). Thus, it is a good method for constructing pH-sensitive micelles to introduce single histidine or polyhistidine into micelles.

Construction of pH-Sensitive Micelles Using Single Histidine

The simplest way to develop micelles containing histidine is to attach hydrophobic histidine to hydrophilic macromolecules, such as hyaluronic acid (Wu et al., 2016), dextran (Yin et al., 2020), and auricularia auricular polysaccharide (AAP) (Wang et al., 2017). In the above micelles, histidine is usually used as a micellar core. Taking histidine-modified AAP (His-AAP) as an example, histidine was linked to AAP by an ester bond. In a neutral medium, His-AAP self-assembled into micelles. Histidine and AAP acted as hydrophobic core and hydrophilic shell, respectively. Next, paclitaxel was loaded into His-AAP micelles. Compared to that at pH 7.4, the paclitaxel accumulated release rate was increased by about 18% for 12 h at pH 5.0 (Wang et al., 2017). Research by Chang et al. (2010) also confirmed that micelles based on histidine had the characteristic of pH-sensitive drug release. N-Boc-histidine was made use of capping PLGA-PEG-PLGA triblock copolymer to prepare histidine-PLGA-PEG-PLGA-histidine. Then, capping triblock polymer self-assembled into micelles. The drug cumulative release rate of DOX-loaded micelles was approximately 20% higher in pH 6.2 medium than that in pH 7.4 medium at 12 h. The elevated accumulative release rate was mainly associated with instability of micellar core, which was caused by ionization of imidazole ring in histidine-PLGA-PEG-PLGA-histidine triblock polymer. In addition, the cumulative release rate of drug-loaded micelles based on PLGA-PEG-PLGA without histidine modification did not differ significantly at pH 6.2 or 7.4, confirming that histidine played a key role in pH-sensitive capacity of micelles.

 Construction of pH-Sensitive Micelles With Polyhistidine

Different from histidine, polyhistidine can construct both pH-sensitive middle layer and core of micelles. Furthermore, how to regulate pH-responsiveness of micelles is an important factor needed to be focused on. Although polyhistidine was used as either an intermediate layer or core of micelles, factors affecting pH-responsiveness differed, which would be introduced separately below.

Factors Affecting pH Response of Micelle When Polyhistidine is Adopted as the Intermediate Layer of Micelles

pH-sensitive capability for polyhistidine as a middle layer of micelles is related to the length of polyhistidine block, namely the number of repeat units of histidine. When the number of repeat units of histidine is relatively small such as 5 and 10, polyhistidine micelles have good capability in pH-sensitive drug release. Therefore, the number of repeat units of histidine is a key factor, which should be considered in the process of designing micelles. In a report, block copolymers HistidinexLysine10 (HisxLys10, x = 0, 5, and 10) conjugated with docosahexaenoic acid (DHA) was designed and prepared to self-assemble into micelles (Wang Y. et al., 2015), in which DHA acted as hydrophobic inner core for DOX loading, polyhistidine served as an intermediate pH-sensitive layer, and polylysine block played as hydrophilic shell. In vitro drug release experiments were performed in three PBS solutions of pH 7.4, 6.0, and 5.0. As shown in Figure 10, at pH 7.4, all three micelles, DHA-Lys10, DHA-His5Lys10, and DHA-His10Lys10, released slowly, and the accumulative DOX release ratio was less than 40% in 100 h. At pH 6.0, DOX release accelerated from both DHA-His5Lys10 and DHA-His10Lys10 micelles, which was attributed to protonation of imidazole groups of some histidine residues in micelles, whereas the rate of DOX release from DHA-His5Lys10 and DHA-His10Lys10 micelles was further speeded up at pH 5.0, especially in the first 10 h. Those results were most likely because the lower pH made more imidazole rings protonate, resulting in the expansion of micellar structure. Furthermore, the longer the histidine block is, the faster the DOX release rate is. In both pH 6.0 and 5.0 media, DOX release from DHA-His10Lys10 micelles was faster than that of DHA-His5Lys10 micelles, and the former micelles had a more complete DOX release within 100 h.

In vitro DOX release from DHA-HisxLys10 (x = 0, 5, 10) micelles at pH 7.4 (A), 6.0 (B), and 5.0 (C) PBS solutions (Wang Y. et al., 2015). Abbreviation: DOX, doxorubicin; DHA, docosahexaenoic acid; His, histidine; Lys, lysine.

However, with increasing the number of repeat units of histidine in micelles, hydrogen-bonding interactions between histidines are probably enhanced, thereby changing the behavior of pH-sensitive drug release. For example, Liu et al. (2012a) used methyl poly(ethylene glycol)-poly(L-histidine)-poly(L-lactide) (mPEG-PH-PLLA) triple block copolymers to investigate the effect of the length of polyhistidine segment on DOX release. At pH 5.0, the cumulative DOX release of mPEG45-PH15-PLLA82 micelles is close to 80% at 24 h, while for mPEG45-PH30-PLA82, the release rate of DOX was 55% at 24 h, and it could not reach 80% until 76 h. It was possible that stronger hydrogen bond interactions existed in polyhistidine of mPEG45-PH30-PLA82, leading to retarded DOX release, compared with mPEG45-PH15-PLLA82. Therefore, when selected as an intermediate layer of micelles, polyhistidine with appropriate chain length can effectively respond to tumor acidic pH microenvironment.

 Factors Affecting pH Response of Micelles When Polyhistidine Acts as Micellar Core

There are two methods to regulate pH-responsiveness of micelles when polyhistidine acts as a micellar core. The first method is to connect hydrophilic polymer block to polyhistidine. pKb value of the whole block copolymer is increased due to the introduction of hydrophilic block segments (Mccurdie and Belfiore, 1999). For example, polyhistidine with a molecular weight of 5,000 had a pKb value of about 6.5 (Lee E. S. et al., 2003). After introducing PEG with a molecular weight of 2,000, a PH (M n 5,000)/PEG (M n 2,000) block copolymer is formed with a pKb value of about 7.0. As pH is below 7.0, the hydrophilicity of poly(L-histidine) chain segment increased for ionization of histidine imidazole groups, leading to instability of micellar core (Jin et al., 2014). This pH-responsive property is good for drug release outside tumor cells. Jin et al. (2014) adopted pH-responsive PH-b-PEG micelles and non-pH-responsive PLLA-b-PEG ones to investigate DOX release capability for pH-sensitive micelles based on polyhistidine. In nude mice xenografted by MDA-MB-231 breast cancer, DOX release from micelles was observed by intravital fluorescence microscopy. For PH-b-PEG micelles, DOX diffused from tumor blood vessels at a faster rate than that of PLLA-b-PEG ones. It was suggested that pH-sensitive PH-b-PEG micelles had a rapid dissociation in tumor acidic pH microenvironment, which might reduce the barrier in tumor blood vessels. Moreover, rapid release of DOX made local drug concentration high within the tumor, thus improving bioavailability of drug. After DOX-loaded PH-b-PEG and PLLA-b-PEG micelles were separately administered via tail vein to nude mice three times at 3-day intervals at a dose of 10 mg/kg, the fluorescence intensity of cells was detected via flow cytometry, which was extracted from tumor tissues. The result showed that the intensity of cellular uptake of DOX supplied from PH-b-PEG micelles was approximately 3.3 times higher than that in PLLA-b-PEG micelles. PH-b-PEG micelles rapidly released in tumor extracellular pH, which not only promoted endocytosis for drug penetration into tumor cells but also led to more effective inhibition of tumor growth. The tumor volume of PLLA-b-PEG micelles treated group was 4.3 times higher than that of PH-b-PEG micelles treated group after 21 d of administration, and the latter group significantly suppressed the growth of tumor volume (p < 0.01) (Figure 11). Above results fully demonstrated that compared with pH-insensitive micelles, it was able for pH-sensitive PH-b-PEG micelles to rapidly disintegrate and trigger drug release in the acidic tumor interstitium.

Effects of DOX-loaded pH-sensitive PH-b-PEG micelles and pH-insensitive PLLA-b-PEG micelles on the growth of MDA 231 breast carcinoma in the window chamber model (Jin et al., 2014). Each formulation was administered three times at 3-day intervals (arrows) at a dose of 10 mg/kg for tumor growth inhibition study. Abbreviation: PEG, poly (ethylene glycol); PH, poly(L-histidine); PLLA, poly(L-lactic acid).

The second approach is that hydrophobic material is introduced into polyhistidine block by blending or copolymerization. It is known that a hydrophobic environment will reduce the local dielectric constant, thereby weakening the ionization tendency of ionizable groups (Benns et al., 2000; Putnam et al., 2001). Thus, hydrophobic material has an inhibitory effect on the ionization of imidazole group in polyhistidine block, which affects the pH value of triggering release of drugs from micelles and modulates the pH-responsiveness of micelles. Moreover, with increasing the content of hydrophobic material, pKb of imidazole groups in polyhistidine block shifts to a lower pH. For example, mixed micelles were prepared by PH (M n 5,000)/PEG (M n 2,000) (PH-b-PEG) and PLLA (M n 3,000)/PEG (M n 2,000) (PLLA-b-PEG) block copolymers (Lee E. et al., 2003). By adjusting the mixing amount of PLLA-b-PEG block copolymer, micelles with different pH-sensitivity could be obtained. When 10 wt.% PLLA-b-PEG was added into PH-b-PEG micelles, it did not change significantly in destabilizing pH, and the destabilization of micelles occurred below pH 8.0. However, 25 wt.% addition of PLLA-b-PEG significantly improved micellar stability, and destabilizing pH was below pH 7.0. Compared to 25 wt.% addition, the destabilizing pH of mixed micelles with 40 wt.% PLLA-b-PEG blend was shifted a bit further downward, which occurred below pH 6.8. It was suggested that the destabilizing pH gradually decreased as the content of PLLA-b-PEG block copolymer increased. Additionally, the results for cumulative release of DOX-loaded mixed micelles for 24 h at different pH were presented in Figure 12. At pH 7.0, mixed micelles containing 10 wt.% PLLA-b-PEG displayed the highest cumulative release amount (more than 60%). And about 32% of DOX was released from mixed micelles with 25 wt.% or 40 wt.% of PLLA-b-PEG. At pH 6.8, three mixed micelles with 10, 25, and 40 wt.% PLLA-b-PEG released approximately 75, 70, and 35%, respectively. At pH 5.0, 10 and 25 wt.% PLLA-b-PEG mixed micelles both achieved a release of more than 80%, and for 40 wt.% PLLA-b-PEG micelle, the drug release was more than 70%. It is probable that at low pH, the imidazole group is ionized on the polyhistidine chain, accompanied by an increase in the hydrophilicity of the polyhistidine chain. As a result, the hydrophobic environment of mixed micelle was disrupted, and PLLA-b-PEG was separated from micelles, leading to micelles disintegration. The added amount of PLLA-b-PEG block copolymer had an effect on the pH value of micellar dissociation. These results suggested that appropriate proportion of PLLA-b-PEG polymer could improve the discrimination and sensitivity of the mixed micelles to the acidic extracellular pH of the tumoral microenvironment.

pH-dependent cumulative adriamycin (ADR) release from the mixed micelles composed of polyHis/PEG and PLLA/PEG [PLLA/PEG content in the mixed micelles: 0 wt.% (●), 10 wt.% (■), 25 wt.% (▲), and 40 wt.% (▼)] (Lee E. et al., 2003).

In another example, poly(histidine-co-phenylalanine) (PHP) was synthesized via the ring-opening polymerization of the benzyl-protected L-histidine NCA and L-phenylalanine NCA (Kim et al., 2008). As the proportion of phenylalanine increased from 10 to 27%, the apparent pKb value of PHP decreased from 6.7 to 4.8. In addition, PHP could be coupled with activated monocarboxylated PEG2000 to form a diblock polymer (PHP-b-PEG). Various PHP-b-PEG polymers were designed by adjusting the molar percentage of phenylalanine in PHP, including PHP(10)-b-PEG, PHP(16)-b-PEG, PHP(22)-b-PEG, and PHP(27)-b-PEG. Above four-block polymers self-assembled to form micelles, which were named as PHSM(10), PHSM(16), PHSM(22), and PHSM(27), respectively. pH-responsiveness of polymeric micelles was evaluated by critical micelle concentration (CMC), particle size, and the light transmittance. In the aspect of CMC, at pH 6.0, CMCs of PHSM(10) and PHSM(16) were above 90 μg ml−1. However, when pH was greater than or equal to 6.5, they significantly increased. The elevated CMC of PHSM(10) and PHSM(16) indicated that both micelles were unstable at low pH. CMCs of PHSM(22) and PHSM(27) were lower than 20 μg ml−1 at pH 6.0 and 6.5, suggesting that they have good stability. In terms of the change of particle size, PHSM(10) and PHSM(16) showed a great difference. The former decreased rapidly, and the latter exhibited a gradual decrease in the range of pH 6.0 ∼ 7.4. Nevertheless, the particle size of PHSM(22) and PHSM(27) had an insignificant change at pH 5.5 and 6.5. The transmissivity of micellar solution was correlated with change in particle size. The transmittance transition points of PHSM(10), PHSM(16), PHSM(22), and PHSM(27) decreased successively at pH 7.0, 6.5, 5.8, and 5.2, respectively. These observations indicated that the introduction of hydrophobic comonomers could adjust pH-sensitivity of micellar core based on polyhistidine.

In the same report, Kim et al. (2008) mixed PHP-b-PEG with PLLA(M n 3,000)-b-PEG(M n 2,000) to design new pH-sensitive micelles with responsiveness to specific pH, which was possible to achieve accurate targeting of tumor organelles. As mentioned above, the destabilizing pH of PHSM(16) was approximately 6.5. When PLLA-b-PEG was introduced into PHP(16)-b-PEG to form mixed micelles, micellar triggering pH could be modulated by the added ratio of PLLA-b-PEG. pH-sensitivity of mixed micelles was determined by the fluorescence intensity of pyrene under different pH conditions, which was shown in Figure 13A. The mixed micelles containing 5, 10, and 20% of PLLA-b-PEG were named as m-PHSM (5%), m-PHSM (10%), and m-PHSM (20%), respectively. For m-PHSM (5%) and m-PHSM (10%), the main change in fluorescence intensity occurred at pH > 6.0. The fluorescence intensity of m-PHSM (20%) altered primarily in the range of 5.5 ∼ 6.0, which was closer to that of early endosomes. Obviously, the sensitivity of m-PHSM to low pH increased with increasing proportion of blended PLLA-b-PEG. This was also confirmed by the release capacity of DOX-loaded m-PHSM (DOX/m-PHSM) at different pH conditions. The 12-h cumulative DOX release from DOX/m-PHSM at pH 6.0 and 6.5 manifested that release of DOX at pH 6.5 decreased with increasing PLLA-b-PEG ratio in micelles and an opposite trend happened at pH 6.0 (Figure 13B). Compared with DOX/m-PHSM (5%) and DOX/m-PHSM (10%), the amount of drug release from DOX/m-PHSM (20%) was the least at pH 6.5, but it was the most at pH 6.0. The rapid release of DOX at pH 6.0 significantly improved the efficacy. In the in-vitro cytotoxicity study, DOX/m-PHSM (20%) was incubated with wild-type human ovarian A2780 for 48 h. The cell viability decreased from ∼75% under pH 6.5 to less than 40% under pH 6.0 (Figure 13C). The above results indicated that m-PHSM (20%) was likely to achieve the targeting of early endosome.

(A) The change of pyrene fluorescence intensity (I 1) with pH at a constant micelle concentration (0.05 g L−1). m-PHSM constructed with the different amounts of PLLA-b-PEG (5%, ▲; 10%, □; 20%, ●) was monitored in NaOH (or HCl)-Na2B4O7 buffer solution (pH 8.0) with exposure to each pH for 24 h. (B) Cumulative amount of DOX for 12 h released from various m-PHSM at pH 6.5 (□) and pH 6.0 (■). (C) Cell viabilities determined by MTT assay of ovarian A2780 wild-type carcinoma cells treated with micelles: free DOX (white), DOX/PHIM (gray), and DOX/m-PHSM(20%) (dark gray). DOX dose was equivalent to 1,000 ng ml−1 in each formulation (Kim et al., 2008). Abbreviation: m-PHSM, pH-sensitive mixed micelles containing poly(histidine (His)-co-phenylalanine (Phe))-b-poly(ethylene glycol) (PEG) and poly(L-lactic acid) (PLLA)-b-PEG; PHIM, pH-insensitive PLLA-b-PEG micelles.

 Arginine-Based Micelles

Arginine possessed some special functions, which were used to fabricate micelles, including cell-membrane-penetrating function and arginine-derived nitric oxide.

Construction of Micelles Utilizing Membrane-Penetrating Function of Arginine

Arginine is a primary component of most cell-penetrating peptides (CPPs), whose guanidine group has a key role in the transmembrane transport of peptides (Schröder et al., 2008; Wender et al., 2008).

Cell-membrane-penetrating ability of arginine is related to the quantity of arginine and the density of guanidine groups. Oligoarginine with more than six repeating units of arginine exhibited perfect membrane-penetration effect (Wang P. et al., 2019; Zhai et al., 2019), and vice versa (Mitchell et al., 2000; Wender et al., 2000). In another example, Macewan and Chilkoti (2012) connected five arginines with hydrophobic segment of amphiphilic elastin-like polypeptides (ELPBCs) to build Arg5-ELPBC with characteristic of temperature sensitivity (Wright and Conticello, 2002; Dreher et al., 2008). Slightly high temperature (e.g. 42°C) could trigger Arg5-ELPBC to self-assemble into micelles, thus resulting in the increase of local arginine density. Confocal microscopy displayed that at 37°C, there was no obvious uptake by Hela cells incubated with Arg5-ELPBC for 1 h, whereas, at 42°C, the self-assembled Arg5-ELPBC micelles showed significantly increased cellular uptake. Moreover, flow cytometry manifested that there was approximately 8-fold difference in cellular uptake for Arg5-ELPBC at 37 and 42°C. It could be inferred that it was an opportunity for polymer containing less than six arginines to realize cell-membrane penetration if only the surface of micelles was covered with high density of arginine guanidine groups by some way. Song Luo’s research (Luo et al., 2016) was consistent with above inference. Specifically, single arginine and pyrene (py) were separately attached to the end of PEG and PCL segment in PEG-b-PCL to construct Arg-PEG-b-PCL-Py copolymer. Next, Arg-PEG-b-PCL-Py copolymer self-assembled into micelles, and guanidine groups of arginine were exposed on the surface of them. In comparison with micelles without modifying arginine, arginine-modified micelles had a more efficient endocytosis and more rapid endo-lysosomal escape (Figure 14), indicating that guanidine-functionalized micelles have a stronger capability to pass through the cell membrane. It was important to note that if it was sufficient for local arginine density on micellar surface, even single arginine-decorated micelles could promote tumor cell internalization.

The CLSM images of 4T1 cells treated with DOX/Arg-PEG-PCL-Py (A) and DOX/Ac-PEG-PCL-Py micelles (B) for 1, 3, and 6 h. The numbers 1, 2, 3, and 4 indicated the bright field, LysoTracker Green fluorescence, DOX fluorescence, and the overlay images, respectively. The concentration of DOX was 10 μg ml−1 (Luo et al., 2016). Abbreviation: Arg-PEG-PCL, arginine-modified poly(ethylene glycol)-b-poly(ε-caprolactone); Ac-PEG-PCL, acetic acid-modified PEG-PCL; Py, pyrene.

 Construction of Micelles Based on Antitumor Ability of Nitric Oxide Derived From Arginine

As early as the 1980s, the immune function of organisms could be regulated by L-arginine (Hibbs et al., 1987). Later, the inhibitory effect of L-arginine on tumor and its mechanism of action were also gradually revealed. Briefly, L-arginine is the substrate of nitric oxide synthase (NOS) (Iyengar et al., 1987). At the early stage of cancer, M1 macrophages infiltrating into tumor tissues overexpress inducible NO synthase (iNOS), which converted L-arginine to NO. The gaseous and lipophilic NO rapidly permeates tumor tissue from M1 macrophages (Thomas et al., 2008). High concentration of NO is cytotoxic and can cause tumor cell apoptosis or induce tumor cell necrosis (Singh et al., 1996; Ambs et al., 1998; Kudo and Nagasaki, 2015).

It has been reported that the increase of L-arginine outside M1 macrophages will upregulate NO (Tsikas et al., 2000). However, systemic administration of free L-arginine is not a good idea, and it is because that there are a lot of problems such as rapid systemic metabolism or excretion, making L-arginine difficult to accumulate at the tumor site (Lind, 2004). But these issues can be solved via the “introducing arginine into nano-micelles” strategy. Owing to the enhanced permeability and retention (EPR) effect of tumor, arginine-rich nano-micelles enabled improved arginine accumulation at the tumor site by passive targeting strategy and generated site-specific high concentration of NO to prevent tumor progression. For instance, Kudo and Nagasaki (2015) synthesized cationic poly((ethylene glycol)-block-poly (L-arginine) (PEG-b-P(L-Arg)) block copolymers with 62 arginine repeating units, which were electrostatically coupled with polyanion chondroitin sulfate (CS) to form a polyionic complex (PIC) micelle with a particle size of about 50 nm and a near-neutral surface charge (average zeta potential: ∼0.09 mV). RAW264.7 macrophages were activated by lipopolysaccharide, which induced the expression of iNOS. The results of in vivo distribution of carriers in tumor-bearing mice confirmed that PIC micelles tended to accumulate in the tumor site, which realized the effective delivery of arginine. Subsequently, to investigate in vivo antitumor activity of PIC micelles (Figure 15), tumor-bearing mice were divided into four groups, which were named as 1-injected group, 2-injected group, 3-injected group, and 4-injected group, respectively. In 1-injected group, tumor-bearing mice received a 16 mg/kg dose of L-arginine by tail vein injection for one time (on day 0), which existed in the PIC micelles. In 2-injected group, the PIC micelles were administered at 16 mg/kg on L-arginine basis for two times (on days 0 and 1, at a total dose of 32 mg/kg). According to the above-mentioned prescription rules, tumor-bearing mice of 3-injected and 4-injected groups were given a corresponding dose of L-arginine. After 12 d in comparison with the control group, there were significant differences in tumor size for four groups. Tumor volume of 1-injected and 2-injected groups was significantly higher than that of the PBS control group (p < 0.05), whereas tumor volume of 3-injected group was close to that of the control group. It was noteworthy that suppression of tumor growth was obviously observed in 4-injected group. These results were also confirmed by Thomas et al. (Hofseth et al., 2003; Thomas et al., 2004). These results showed that the antitumor effect of NO depended on its concentration. Low-dose NO promoted tumor growth, whereas high-dose one inhibited tumor growth. The one possible reason is that low concentration of NO could enhance angiogenesis, thus promoting tumor growth. In contrast, high concentration of NO could lead to tumor cell apoptosis, along with inhibiting tumor growth. Therefore, it is helpful for designing arginine-rich micelles to enhance the therapeutic effect of tumor.

Tumor growth curve of tumor-bearing mice after the first injection of PEG-b-P(L-Arg)/m (Kudo and Nagasaki, 2015). The number of injections was changed from 1 up to 4 times on days 0–3 at a dose of 16 mg/kg on an arginine basis. Injection times are 1 (closed circles), 2 (open triangles), 3 (closed triangles), and 4 (open lozenges). Tumor volume change of PBS-treated mice was also shown as open squares. (n = 4, expressed as mean ± S.E., *p < 0.05). Abbreviation: P(L-Arg), poly(L-Arginine); m, micelles.

 Conclusion

Material safety is one of the main problems that affect the development of micelles from basic research to clinical application. Raw materials for building micelles were derived from various natural and synthetic materials. Compared to synthetic materials, natural materials have almost no side effect on human body, which become the first choice for micelles. In natural materials, basic amino acids have been paid much attention for non-toxicity and good biocompatibility.

This review shows design ideas for the construction of micelles by using basic amino acids and their derivatives. It can be summarized as follows:

1) Lysine and its derivatives can build the linker, core, and shell of micelles. As linker, lysine, lysine-based dendrimer, and polylysine provide the rich active groups to connect hydrophilic or hydrophobic materials. Additionally, the surplus amino groups of polylysine as linker can load drug by electrostatic interaction or are covalently cross-linked by introducing disulfide bond, thus improving the stability of drug-loaded micelles. In the construction of micellar core, polylysine can be physically combined with negatively charged polymer by electrostatic interaction, or chemically modified in the side chain amino groups to form micellar core. Modification methods for side-chain amino group of polylysine include charge reversal of polylysine by introducing carboxyl groups, cross-linking of polylysine by introducing sulfhydryl groups, and hydrophobic modification of polylysine by introducing hydrophobic molecules. When acting as the shell of micelles, the positive charge of polylysine is shielded by introducing drug, anionic substances, or polymers to temporarily occupy the amino groups, thereby reducing or reversing the charge of drug-loaded micelles, improving their stability in the blood circulation, and enhancing their efficiency of endocytosis by target cells.

2) Both histidine and polyhistidine can act as the core of micelles to load drug and trigger drug release by acidic pH. When introducing hydrophobic material into the micellar core based on polyhistidine, either by mixing hydrophobic polymer blocks or by introducing other hydrophobic components into the polyhistidine blocks, the ability of micelles to recognize small differences in pH is improved thus achieving accurate targeting of tumor organelles. In addition, polyhistidine as an intermediate layer of triblock polymer micelles can control drug release rate by responding to acidic pH. There is a correlation between the chain length of polyhistidine as the middle layer of micelles and pH-dependent drug release rate.

3) The micelles modified by both single arginine and oligoarginine have high membrane-penetrating ability due to covering the outside of micelles with high density of arginine guanidine groups. Moreover, the high concentration of arginine-rich micelles in tumor site can generate high concentration of NO to enhance antitumor effect.

Considerable progress has been made in the construction of drug-loaded micelles based on lysine, histidine, and arginine, and efficient drug delivery at the target site has been achieved. In addition, cytotoxicity and intracellular delivery processes have been widely studied in many researches. Nevertheless, there are still the following problems to be solved: 1) micelles based on basic amino acids are still produced on a laboratory scale, and issues related to low yield and high cost need to be resolved; 2) most of the researches in drug delivery are only at the basic research stage of cell and animal models. Information was limited on biodistribution, metabolism, and degradation mechanisms of amino acid-based micelles. In order to obtain better biomedical applications, the further corresponding studies related to the above unsolved issues are necessary.

 Data Availability Statement

The original contributions presented in the study are included in the article/supplementary material; further inquiries can be directed to the corresponding author.

 Author Contributions

RL directed the completion of this article. LX wrote the main content of this article. XC, MH, YZ, and SC collected the information for this article. All authors contributed to the article and approved the submitted version.

 Funding

This work was supported by the National Natural Science Foundation of China (No: 51203157); Antibiotics Research and Re-evaluation Key Laboratory Foundation of Sichuan Province (No: ARRLKF15-04); and Project of Education Department in Sichuan Province (No: 16ZB0421).

 Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

 Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

 References Adityan S. Tran M. Bhavsar C. Wu S. Y. (2020). Nano-therapeutics for Modulating the Tumour Microenvironment: Design, Development, and Clinical Translation. J. Controlled Release 327, 512–532. 10.1016/j.jconrel.2020.08.016 Ambs S. Merriam W. G. Ogunfusika M. O. Bennett W. P. Ishibe N. Hussain S. P. (1998). p53 and Vascular Endothelial Growth Factor Regulate Tumor Growth of NOS2-Expressing Human Carcinoma Cells. Nat. Med. 4, 1371–1376. 10.1038/3957 Augustine R. Kim D.-K. Kalva N. Eom K. H. Kim J. H. Kim I. (2020a). Multi-stimuli-responsive Nanomicelles Fabricated Using Synthetic Polymer Polylysine Conjugates for Tumor Microenvironment Dependent Drug Delivery. J. Mater. Chem. B 8, 5745–5755. 10.1039/D0TB00721H Augustine R. Kim D.-K. Kim H. A. Kim J. H. Kim I. (2020b). Poly(N-isopropylacrylamide)-b-Poly(L-lysine)-b-Poly(L-histidine) Triblock Amphiphilic Copolymer Nanomicelles for Dual-Responsive Anticancer Drug Delivery. j nanosci nanotechnol 20, 6959–6967. 10.1166/jnn.2020.18822 Aw M. S. Simovic S. Addai-Mensah J. Losic D. (2011). Polymeric Micelles in Porous and Nanotubular Implants as a New System for Extended Delivery of Poorly Soluble Drugs. J. Mater. Chem. 21, 7082–7089. 10.1039/C0JM04307A Benns J. M. Choi J.-S. Mahato R. I. Park J.-S. Kim S. W. (2000). pH-Sensitive Cationic Polymer Gene Delivery Vehicle: N-Ac-Poly(l-Histidine)-Graft-Poly(l-Lysine) Comb Shaped Polymer. Bioconjug. Chem. 11, 637–645. 10.1021/bc0000177 Beyermann J. Kukula H. (2000). Poly(ethylene Oxide)-B-Poly(l-Lysine) Complexes with Retinoic Acid. Macromolecules 33, 5906–5911. 10.1021/ma000629m Boudier A. Aubert-Pouëssel A. Gérardin C. Devoisselle J.-M. Bégu S. (2009). pH-sensitive Double-Hydrophilic Block Copolymer Micelles for Biological Applications. Int. J. Pharmaceutics 379, 212–217. 10.1016/j.ijpharm.2009.05.032 Boudier A. Aubert-Pouëssel A. Mebarek N. Chavanieu A. Quentin J. Martire D. (2011). Development of Tripartite Polyion Micelles for Efficient Peptide Delivery into Dendritic Cells without Altering Their Plasticity. J. Controlled Release 154, 156–163. 10.1016/j.jconrel.2011.05.016 Boulikas T. Pantos T. Bellis E. Christofis P. (2007). Designing Platinum Compounds in Cancer: Structures and Mechanisms. Cancer Ther. 5, 537–583. Brunato S. Mastrotto F. Bellato F. Bastiancich C. Travanut A. Garofalo M. (2021). PEG-polyaminoacid Based Micelles for Controlled Release of Doxorubicin: Rational Design, Safety and Efficacy Study. J. Controlled Release 335, 21–37. 10.1016/j.jconrel.2021.05.010 Cabral H. Kataoka K. (2014). Progress of Drug-Loaded Polymeric Micelles into Clinical Studies. J. Controlled Release 190, 465–476. 10.1016/j.jconrel.2014.06.042 Canfield C.-A. Bradshaw P. C. (2019). Amino Acids in the Regulation of Aging and Aging-Related Diseases. Translational Med. Aging 3, 70–89. 10.1016/j.tma.2019.09.001 Chang C. Liang P. Chen L. Liu J. Chen S. Zheng G. (2017). pH-responsive Nanoparticle Assembly from Peptide Amphiphiles for Tumor Targeting Drug Delivery. J. Biomater. Sci. Polym. Edition 28, 1338–1350. 10.1080/09205063.2017.1325095 Chang G. Li C. Lu W. Ding J. (2010). N-Boc-Histidine-Capped PLGA-PEG-PLGA as a Smart Polymer for Drug Delivery Sensitive to Tumor Extracellular pH. Macromol. Biosci. 10, 1248–1256. 10.1002/mabi.201000117 Chen J. Ding J. Zhang Y. Xiao C. Zhuang X. Chen X. (2015). Polyion Complex Micelles with Gradient pH-Sensitivity for Adjustable Intracellular Drug Delivery. Polym. Chem. 6, 397–405. 10.1039/C4PY01149J Cheng F. Pan Q. Gao W. Pu Y. Luo K. He B. (2021). Reversing Chemotherapy Resistance by a Synergy between Lysosomal pH-Activated Mitochondrial Drug Delivery and Erlotinib-Mediated Drug Efflux Inhibition. ACS Appl. Mater. Interfaces 13, 29257–29268. 10.1021/acsami.1c03196 Deng C. Jiang Y. Cheng R. Meng F. Zhong Z. (2012). Biodegradable Polymeric Micelles for Targeted and Controlled Anticancer Drug Delivery: Promises, Progress and Prospects. Nano Today 7, 467–480. 10.1016/j.nantod.2012.08.005 Deshmukh A. S. Chauhan P. N. Noolvi M. N. Chaturvedi K. Ganguly K. Shukla S. S. (2017). Polymeric Micelles: Basic Research to Clinical Practice. Int. J. Pharmaceutics 532, 249–268. 10.1016/j.ijpharm.2017.09.005 Ding J. Chen J. Li D. Xiao C. Zhang J. He C. (2013). Biocompatible Reduction-Responsive Polypeptide Micelles as Nanocarriers for Enhanced Chemotherapy Efficacy In Vitro . J. Mater. Chem. B 1, 69–81. 10.1039/C2TB00063F Dirisala A. Osada K. Chen Q. Tockary T. A. Machitani K. Osawa S. (2014). Optimized Rod Length of Polyplex Micelles for Maximizing Transfection Efficiency and Their Performance in Systemic Gene Therapy against Stroma-Rich Pancreatic Tumors. Biomaterials 35, 5359–5368. 10.1016/j.biomaterials.2014.03.037 Dreher M. R. Simnick A. J. Fischer K. Smith R. J. Patel A. Schmidt M. (2008). Temperature Triggered Self-Assembly of Polypeptides into Multivalent Spherical Micelles. J. Am. Chem. Soc. 130, 687–694. 10.1021/ja0764862 Du J.-Z. Sun T.-M. Song W.-J. Wu J. Wang J. (2010). A Tumor-Acidity-Activated Charge-Conversional Nanogel as an Intelligent Vehicle for Promoted Tumoral-Cell Uptake and Drug Delivery. Angew. Chem. Int. Edition 49, 3621–3626. 10.1002/anie.200907210 Fukumura D. Jain R. K. (2007). Tumor Microvasculature and Microenvironment: Targets for Anti-angiogenesis and Normalization. Microvasc. Res. 74, 72–84. 10.1016/j.mvr.2007.05.003 Geihe E. I. Cooley C. B. Simon J. R. Kiesewetter M. K. Edward J. A. Hickerson R. P. (2012). Designed Guanidinium-Rich Amphipathic Oligocarbonate Molecular Transporters Complex, Deliver and Release siRNA in Cells. Proc. Natl. Acad. Sci. 109, 13171–13176. 10.1073/pnas.1211361109 George A. Shah P. A. Shrivastav P. S. (2019). Natural Biodegradable Polymers Based Nano-Formulations for Drug Delivery: A Review. Int. J. Pharmaceutics 561, 244–264. 10.1016/j.ijpharm.2019.03.011 Grossen P. Witzigmann D. Sieber S. Huwyler J. (2017). PEG-PCL-based Nanomedicines: A Biodegradable Drug Delivery System and its Application. J. Controlled Release 260, 46–60. 10.1016/j.jconrel.2017.05.028 Guan J. Zhou Z.-Q. Chen M.-H. Li H.-Y. Tong D.-N. Yang J. (2017). Folate-conjugated and pH-Responsive Polymeric Micelles for Target-cell-specific Anticancer Drug Delivery. Acta Biomater. 60, 244–255. 10.1016/j.actbio.2017.07.018 Guan S. Zhang Q. Bao J. Duan T. Hu R. Czech T. (2020). Phosphatidylserine Targeting Peptide-Functionalized pH Sensitive Mixed Micelles for Enhanced Anti-tumor Drug Delivery. Eur. J. Pharmaceutics Biopharmaceutics 147, 87–101. 10.1016/j.ejpb.2019.12.012 Guo D. Shi C. Wang L. Ji X. Zhang S. Luo J. (2020). Rationally Designed Micellar Nanocarriers for the Delivery of Hydrophilic Methotrexate in Psoriasis Treatment. ACS Appl. Bio Mater. 3, 4832–4846. 10.1021/acsabm.0c00342 Gupta R. Shea J. Scaife C. Shurlygina A. Rapoport N. (2015). Polymeric Micelles and Nanoemulsions as Drug Carriers: Therapeutic Efficacy, Toxicity, and Drug Resistance. J. Controlled Release 212, 70–77. 10.1016/j.jconrel.2015.06.019 Harada-Shiba M. Yamauchi K. Harada A. Takamisawa I. Shimokado K. Kataoka K. (2002). Polyion Complex Micelles as Vectors in Gene Therapy - Pharmacokinetics and In Vivo Gene Transfer. Gene Ther. 9, 407–414. 10.1038/sj.gt.3301665 He B. Liu B. He B. Li Y. Lai J. Tang J. Z. (2012a). Effects of pH-Sensitive Chain Length on Release of Doxorubicin from mPEG-B-PH-B-PLLA Nanoparticles. Ijn 7, 4433. 10.2147/IJN.S32053 Hibbs J. Taintor R. Vavrin Z. (1987). Macrophage Cytotoxicity: Role for L-Arginine Deiminase and Imino Nitrogen Oxidation to Nitrite. Science 235, 473–476. 10.1126/science.2432665 Hofseth L. J. Saito S. Hussain S. P. Espey M. G. Miranda K. M. Araki Y. (2003). Nitric Oxide-Induced Cellular Stress and P53 Activation in Chronic Inflammation. Proc. Natl. Acad. Sci. 100, 143–148. 10.1073/pnas.0237083100 Hu X. Liu G. Li Y. Wang X. Liu S. (2015). Cell-Penetrating Hyperbranched Polyprodrug Amphiphiles for Synergistic Reductive Milieu-Triggered Drug Release and Enhanced Magnetic Resonance Signals. J. Am. Chem. Soc. 137, 362–368. 10.1021/ja5105848 Itaka K. Yamauchi K. Harada A. Nakamura K. Kawaguchi H. Kataoka K. (2003). Polyion Complex Micelles from Plasmid DNA and Poly(ethylene Glycol)-Poly(l-Lysine) Block Copolymer as Serum-Tolerable Polyplex System: Physicochemical Properties of Micelles Relevant to Gene Transfection Efficiency. Biomaterials 24, 4495–4506. 10.1016/S0142-9612(03)00347-8 Iyengar R. Stuehr D. J. Marletta M. A. (1987). Macrophage Synthesis of Nitrite, Nitrate, and N-Nitrosamines: Precursors and Role of the Respiratory Burst. Proc. Natl. Acad. Sci. 84, 6369–6373. 10.1073/pnas.84.18.6369 Jang W.-D. Nakagishi Y. Nishiyama N. Kawauchi S. Morimoto Y. Kikuchi M. (2006). Polyion Complex Micelles for Photodynamic Therapy: Incorporation of Dendritic Photosensitizer Excitable at Long Wavelength Relevant to Improved Tissue-Penetrating Property. J. Controlled Release 113, 73–79. 10.1016/j.jconrel.2006.03.009 Jiao X. Yu Y. Meng J. He M. Zhang C. J. Geng W. (2019). Dual-targeting and Microenvironment-Responsive Micelles as a Gene Delivery System to Improve the Sensitivity of Glioma to Radiotherapy. Acta Pharmaceutica Sinica B 9, 381–396. 10.1016/j.apsb.2018.12.001 Jin Z.-h. Jin M.-j. Jiang C.-g. Yin X.-z. Jin S.-x. Quan X.-q. (2014). Evaluation of Doxorubicin-Loaded pH-Sensitive Polymeric Micelle Release from Tumor Blood Vessels and Anticancer Efficacy Using a Dorsal Skin-fold Window Chamber Model. Acta Pharmacol. Sin. 35, 839–845. 10.1038/aps.2014.12 Jones D. P. Carlson J. L. Samiec P. S. Sternberg P. Mody V. C. Reed R. L. (1998). Glutathione Measurement in Human Plasma. Clinica Chim. Acta 275, 175–184. 10.1016/S0009-8981(98)00089-8 Kang Y. Lu L. Lan J. Ding Y. Yang J. Zhang Y. (2018). Redox-responsive Polymeric Micelles Formed by Conjugating Gambogic Acid with Bioreducible Poly(amido Amine)s for the Co-delivery of Docetaxel and MMP-9 shRNA. Acta Biomater. 68, 137–153. 10.1016/j.actbio.2017.12.028 Kanto R. Yonenuma R. Yamamoto M. Furusawa H. Yano S. Haruki M. (2021). Mixed Polyplex Micelles with Thermoresponsive and Lysine-Based Zwitterionic Shells Derived from Two Poly(vinyl Amine)-Based Block Copolymers. Langmuir 37, 3001–3014. 10.1021/acs.langmuir.0c02197 Kelly B. Pearce E. L. (2020). Amino Assets: How Amino Acids Support Immunity. Cel Metab. 32, 154–175. 10.1016/j.cmet.2020.06.010 Khoury A. Deo K. M. Aldrich-Wright J. R. (2020). Recent Advances in Platinum-Based Chemotherapeutics that Exhibit Inhibitory and Targeted Mechanisms of Action. J. Inorg. Biochem. 207, 111070. 10.1016/j.jinorgbio.2020.111070 Kim D. Lee E. S. Oh K. T. Gao Z. G. Bae Y. H. (2008). Doxorubicin-Loaded Polymeric Micelle Overcomes Multidrug Resistance of Cancer by Double-Targeting Folate Receptor and Early Endosomal pH. Small 4, 2043–2050. 10.1002/smll.200701275 Kim S. G. Robby A. I. Lee B. C. Lee G. Park S. Y. (2021). Mitochondria-targeted ROS- and GSH-Responsive Diselenide-Crosslinked Polymer Dots for Programmable Paclitaxel Release. J. Ind. Eng. Chem. 99, 98–106. 10.1016/j.jiec.2021.04.016 Knudsen K. B. Northeved H. Kumar Ek P. P. Permin A. Gjetting T. Andresen T. L. (2015). In Vivo toxicity of Cationic Micelles and Liposomes. Nanomedicine: Nanotechnology, Biol. Med. 11, 467–477. 10.1016/j.nano.2014.08.004 Koo A. N. Lee H. J. Kim S. E. Chang J. H. Park C. Kim C. (2008). Disulfide-cross-linked PEG-Poly(amino Acid)s Copolymer Micelles for Glutathione-Mediated Intracellular Drug Delivery. Chem. Commun., 6570–6572. 10.1039/B815918A Koo A. N. Min K. H. Lee H. J. Lee S.-U. Kim K. Chan Kwon I. (2012). Tumor Accumulation and Antitumor Efficacy of Docetaxel-Loaded Core-Shell-corona Micelles with Shell-specific Redox-Responsive Cross-Links. Biomaterials 33, 1489–1499. 10.1016/j.biomaterials.2011.11.013 Krivitsky A. Polyak D. Scomparin A. Eliyahu S. Ofek P. Tiram G. (2018). Amphiphilic Poly(α)glutamate Polymeric Micelles for Systemic Administration of siRNA to Tumors. Nanomedicine: Nanotechnology, Biol. Med. 14, 303–315. 10.1016/j.nano.2017.10.012 Kudo S. Nagasaki Y. (2015). A Novel Nitric Oxide-Based Anticancer Therapeutics by Macrophage-Targeted Poly(l-Arginine)-Based Nanoparticles. J. Controlled Release 217, 256–262. 10.1016/j.jconrel.2015.09.019 Lee E. Na K. Bae Y. H. (2003). Polymeric Micelle for Tumor pH and Folate-Mediated Targeting. J. Controlled Release 91, 103–113. 10.1016/S0168-3659(03)00239-6 Lee E. S. Gao Z. Bae Y. H. (2008). Recent Progress in Tumor pH Targeting Nanotechnology. J. Controlled Release 132, 164–170. 10.1016/j.jconrel.2008.05.003 Lee E. S. Shin H. J. Na K. Bae Y. H. (2003). Poly(l-histidine)-PEG Block Copolymer Micelles and pH-Induced Destabilization. J. Controlled Release 90, 363–374. 10.1016/S0168-3659(03)00205-0 Li Y. Gao F. Guo J. Ren P. Tian Z. Bai J. (2020). Polymeric Micelles with Aggregation-Induced Emission Based on Microbial ε-polylysine for Doxorubicin Delivery. Eur. Polym. J. 122, 109355. 10.1016/j.eurpolymj.2019.109355 Li Y. Xiao K. Luo J. Xiao W. Lee J. S. Gonik A. M. (2011). Well-defined, Reversible Disulfide Cross-Linked Micelles for On-Demand Paclitaxel Delivery. Biomaterials 32, 6633–6645. 10.1016/j.biomaterials.2011.05.050 Lin J.-T. Zou Y. Wang C. Zhong Y.-C. Zhao Y. Zhu H.-E. (2014). Cationic Micellar Nanoparticles for DNA and Doxorubicin Co-delivery. Mater. Sci. Eng. C 44, 430–439. 10.1016/j.msec.2014.07.049 Lind D. S. (2004). Arginine and Cancer. J. Nutr. 134, 2837S–2841S. 10.1093/jn/134.10.2837S Liu R. He B. Li D. Lai Y. Tang J. Z. Gu Z. (2012b). Stabilization of pH-Sensitive mPEG-PH-PLA Nanoparticles by Stereocomplexation between Enantiomeric Polylactides. Macromol. Rapid Commun. 33, 1061–1066. 10.1002/marc.201100854 Liu S.-T. Tuan-Mu H.-Y. Hu J.-J. Jan J.-S. (2015). Genipin Cross-Linked PEG-Block-poly(L-Lysine)/disulfide-Based Polymer Complex Micelles as Fluorescent Probes and pH-/redox-Responsive Drug Vehicles. RSC Adv. 5, 87098–87107. 10.1039/C5RA18802D Lu C. Wen T. Zheng M. Liu D. Quan G. Pan X. (2020). Poly(Ethylene Glycol) Crosslinked Multi-Armed Poly(l-Lysine) with Encapsulating Capacity and Antimicrobial Activity for the Potential Treatment of Infection-Involved Multifactorial Diseases. Pharmaceutics 12, 47. 10.3390/pharmaceutics12010047 Luo S. Zhang Y. Cao J. He B. Li S. (2016). Arginine Modified Polymeric Micelles as a Novel Drug Delivery System with Enhanced Endocytosis Efficiency. Colloids Surf. B: Biointerfaces 148, 181–192. 10.1016/j.colsurfb.2016.07.023 Luo Z. Li P. Deng J. Gao N. Zhang Y. Pan H. (2013). Cationic Polypeptide Micelle-Based Antigen Delivery System: A Simple and Robust Adjuvant to Improve Vaccine Efficacy. J. Controlled Release 170, 259–267. 10.1016/j.jconrel.2013.05.027 Lv S. Song W. Tang Z. Li M. Yu H. Hong H. (2014). Charge-Conversional PEG-Polypeptide Polyionic Complex Nanoparticles from Simple Blending of a Pair of Oppositely Charged Block Copolymers as an Intelligent Vehicle for Efficient Antitumor Drug Delivery. Mol. Pharmaceutics 11, 1562–1574. 10.1021/mp4007387 Ma J. Zhang J. Chi L. Liu C. Li Y. Tian H. (2020). Preparation of Poly(glutamic Acid) Shielding Micelles Self-Assembled from Polylysine-B-Polyphenylalanine for Gene and Drug Codelivery. Chin. Chem. Lett. 31, 1427–1431. 10.1016/j.cclet.2020.02.034 Macewan S. R. Chilkoti A. (2012). Digital Switching of Local Arginine Density in a Genetically Encoded Self-Assembled Polypeptide Nanoparticle Controls Cellular Uptake. Nano Lett. 12, 3322–3328. 10.1021/nl301529p Mccurdie M. P. Belfiore L. A. (1999). Solid-state Complexes of poly(L-Histidine) with Metal Chlorides from the First Row of Thed-Block. J. Polym. Sci. B Polym. Phys. 37, 301–309. 10.1002/(SICI)1099-0488(19990215)37:4<301::AID-POLB4>3.0.CO;2-H Mebarek N. Aubert-Pouëssel A. Gérardin C. Vicente R. Devoisselle J.-M. Bégu S. (2013). Polymeric Micelles Based on Poly(methacrylic Acid) Block-Containing Copolymers with Different Membrane Destabilizing Properties for Cellular Drug Delivery. Int. J. Pharmaceutics 454, 611–620. 10.1016/j.ijpharm.2013.06.014 Mitchell D. J. Steinman L. Kim D. T. Fathman C. G. Rothbard J. B. (2000). Polyarginine Enters Cells More Efficiently Than Other Polycationic Homopolymers. J. Pept. Res. 56, 318–325. 10.1034/j.1399-3011.2000.00723.x Miyata K. Kakizawa Y. Nishiyama N. Harada A. Yamasaki Y. Koyama H. (2004). Block Catiomer Polyplexes with Regulated Densities of Charge and Disulfide Cross-Linking Directed to Enhance Gene Expression. J. Am. Chem. Soc. 126, 2355–2361. 10.1021/ja0379666 Nishiyama N. Nakagishi Y. Morimoto Y. Lai P.-S. Miyazaki K. Urano K. (2009). Enhanced Photodynamic Cancer Treatment by Supramolecular Nanocarriers Charged with Dendrimer Phthalocyanine. J. Controlled Release 133, 245–251. 10.1016/j.jconrel.2008.10.010 Oe Y. Christie R. J. Naito M. Low S. A. Fukushima S. Toh K. (2014). Actively-targeted Polyion Complex Micelles Stabilized by Cholesterol and Disulfide Cross-Linking for Systemic Delivery of siRNA to Solid Tumors. Biomaterials 35, 7887–7895. 10.1016/j.biomaterials.2014.05.041 Ohya Y. Takeda S. Shibata Y. Ouchi T. Kano A. Iwata T. (2011). Evaluation of Polyanion-Coated Biodegradable Polymeric Micelles as Drug Delivery Vehicles. J. Controlled Release 155, 104–110. 10.1016/j.jconrel.2010.11.008 Ohya Y. Takeda S. Shibata Y. Ouchi T. Maruyama A. (2010). Preparation of Highly Stable Biodegradable Polymer Micelles by Coating with Polyion Complex. Macromol. Chem. Phys. 211, 1750–1756. 10.1002/macp.201000167 Osada K. Oshima H. Kobayashi D. Doi M. Enoki M. Yamasaki Y. (2010). Quantized Folding of Plasmid DNA Condensed with Block Catiomer into Characteristic Rod Structures Promoting Transgene Efficacy. J. Am. Chem. Soc. 132, 12343–12348. 10.1021/ja102739b Osada K. Shiotani T. Tockary T. A. Kobayashi D. Oshima H. Ikeda S. (2012). Enhanced Gene Expression Promoted by the Quantized Folding of pDNA within Polyplex Micelles. Biomaterials 33, 325–332. 10.1016/j.biomaterials.2011.09.046 Oupicky D. Ogris M. Howard K. A. Dash P. R. Ulbrich K. Seymour L. W. (2002). Importance of Lateral and Steric Stabilization of Polyelectrolyte Gene Delivery Vectors for Extended Systemic Circulation. Mol. Ther. 5, 463–472. 10.1006/mthe.2002.0568 Pittella F. Zhang M. Lee Y. Kim H. J. Tockary T. Osada K. (2011). Enhanced Endosomal Escape of siRNA-Incorporating Hybrid Nanoparticles from Calcium Phosphate and PEG-Block Charge-Conversional Polymer for Efficient Gene Knockdown with Negligible Cytotoxicity. Biomaterials 32, 3106–3114. 10.1016/j.biomaterials.2010.12.057 Putnam D. Gentry C. A. Pack D. W. Langer R. (2001). Polymer-based Gene Delivery with Low Cytotoxicity by a Unique Balance of Side-Chain Termini. Proc. Natl. Acad. Sci. 98, 1200–1205. 10.1073/pnas.98.3.1200 Schröder T. Niemeier N. Afonin S. Ulrich A. S. Krug H. F. Bräse S. (2008). Peptoidic Amino- and Guanidinium-Carrier Systems: Targeted Drug Delivery into the Cell Cytosol or the Nucleus. J. Med. Chem. 51, 376–379. 10.1021/jm070603m Singh S. P. Wishnok J. S. Keshive M. Deen W. M. Tannenbaum S. R. (1996). The Chemistry of the S-Nitrosoglutathione/glutathione System. Proc. Natl. Acad. Sci. 93, 14428–14433. 10.1073/pnas.93.25.14428 Song H. Wang R. Xiao H. Cai H. Zhang W. Xie Z. (2013). A Cross-Linked Polymeric Micellar Delivery System for Cisplatin(IV) Complex. Eur. J. Pharmaceutics Biopharmaceutics 83, 63–75. 10.1016/j.ejpb.2012.09.004 Sugisaki K. Usui T. Nishiyama N. Jang W.-D. Yanagi Y. Yamagami S. (2008). Photodynamic Therapy for Corneal Neovascularization Using Polymeric Micelles Encapsulating Dendrimer Porphyrins. Invest. Ophthalmol. Vis. Sci. 49, 894–899. 10.1167/iovs.07-0389 Sun H. Guo B. Cheng R. Meng F. Liu H. Zhong Z. (2009). Biodegradable Micelles with Sheddable Poly(ethylene Glycol) Shells for Triggered Intracellular Release of Doxorubicin. Biomaterials 30, 6358–6366. 10.1016/j.biomaterials.2009.07.051 Takeda K. M. Yamasaki Y. Dirisala A. Ikeda S. Tockary T. A. Toh K. (2017). Effect of Shear Stress on Structure and Function of Polyplex Micelles from Poly(ethylene Glycol)-Poly( L -lysine) Block Copolymers as Systemic Gene Delivery Carrier. Biomaterials 126, 31–38. 10.1016/j.biomaterials.2017.02.012 Teng F. Deng P. Song Z. Zhou F. Feng R. Liu N. (2017). In Vitro characterization of pH-Sensitive Azithromycin-Loaded Methoxy Poly (Ethylene Glycol)-Block-Poly (Aspartic Acid-Graft-Imidazole) Micelles. J. Colloid Interf. Sci. 496, 16–25. 10.1016/j.jcis.2017.02.011 Thambi T. Son S. Lee D. S. Park J. H. (2016). Poly(ethylene Glycol)-B-Poly(lysine) Copolymer Bearing Nitroaromatics for Hypoxia-Sensitive Drug Delivery. Acta Biomater. 29, 261–270. 10.1016/j.actbio.2015.10.011 Thomas D. D. Espey M. G. Ridnour L. A. Hofseth L. J. Mancardi D. Harris C. C. (2004). Hypoxic Inducible Factor 1α, Extracellular Signal-Regulated Kinase, and P53 Are Regulated by Distinct Threshold Concentrations of Nitric Oxide. Pnas 101, 8894–8899. 10.1073/pnas.0400453101 Thomas D. D. Ridnour L. A. Isenberg J. S. Flores-Santana W. Switzer C. H. Donzelli S. (2008). The Chemical Biology of Nitric Oxide: Implications in Cellular Signaling. Free Radic. Biol. Med. 45, 18–31. 10.1016/j.freeradbiomed.2008.03.020 Tsikas D. Böger R. H. Sandmann J. Bode-Böger S. M. Frölich J. C. (2000). Endogenous Nitric Oxide Synthase Inhibitors Are Responsible for theL-Arginine Paradox. FEBS Lett. 478, 1–3. 10.1016/S0014-5793(00)01686-0 Vachutinsky Y. Oba M. Miyata K. Hiki S. Kano M. R. Nishiyama N. (2011). Antiangiogenic Gene Therapy of Experimental Pancreatic Tumor by sFlt-1 Plasmid DNA Carried by RGD-Modified Crosslinked Polyplex Micelles. J. Controlled Release 149, 51–57. 10.1016/j.jconrel.2010.02.002 Wang J. Sun J. Chen Q. Gao Y. Li L. Li H. (2012). Star-shape Copolymer of Lysine-Linked Di-tocopherol Polyethylene Glycol 2000 Succinate for Doxorubicin Delivery with Reversal of Multidrug Resistance. Biomaterials 33, 6877–6888. 10.1016/j.biomaterials.2012.06.019 Wang J. Xu W. Guo H. Ding J. Chen J. Guan J. (2015a). Selective Intracellular Drug Delivery from pH-Responsive Polyion Complex Micelle for Enhanced Malignancy Suppression In Vivo . Colloids Surf. B: Biointerfaces 135, 283–290. 10.1016/j.colsurfb.2015.07.065 Wang P. Liu W. Liu S. Yang R. Pu Y. Zhang W. (2019). pH-responsive Nanomicelles of Poly(ethylene Glycol)-Poly(ε-Caprolactone)-poly(L-Histidine) for Targeted Drug Delivery. J. Biomater. Sci. Polym. Edition 31, 277–292. 10.1080/09205063.2019.1687132 Wang Y. Li P. Chen F. Jia L. Xu Q. Gai X. (2017). A Novel pH-Sensitive Carrier for the Delivery of Antitumor Drugs: Histidine-Modified Auricularia Auricular Polysaccharide Nano-Micelles. Sci. Rep. 7, 4751. 10.1038/s41598-017-04428-8 Wang Y. Li Q. Y. Liu X. B. Zhang C. Y. Wu Z. M. Guo X. D. (2015b). Mesoscale Simulations and Experimental Studies of pH-Sensitive Micelles for Controlled Drug Delivery. ACS Appl. Mater. Inter. 7, 25592–25600. 10.1021/acsami.5b08366 Wang Y. Yang T. Wang X. Dai W. Wang J. Zhang X. (2011). Materializing Sequential Killing of Tumor Vasculature and Tumor Cells via Targeted Polymeric Micelle System. J. Controlled Release 149, 299–306. 10.1016/j.jconrel.2010.10.027 Wang Z. Zhang Y. Cao B. Ji Z. Luo W. Zhai S. (2019). Explosible Nanocapsules Excited by Pulsed Microwaves for Efficient Thermoacoustic-Chemo Combination Therapy. Nanoscale 11, 1710–1719. 10.1039/C8NR08498J Wen H.-Y. Dong H.-Q. Xie W.-j. Li Y.-Y. Wang K. Pauletti G. M. (2011). Rapidly Disassembling Nanomicelles with Disulfide-Linked PEG Shells for Glutathione-Mediated Intracellular Drug Delivery. Chem. Commun. 47, 3550–3552. 10.1039/C0CC04983B Wender P. A. Galliher W. C. Goun E. A. Jones L. R. Pillow T. H. (2008). The Design of Guanidinium-Rich Transporters and Their Internalization Mechanisms. Adv. Drug Deliv. Rev. 60, 452–472. 10.1016/j.addr.2007.10.016 Wender P. A. Mitchell D. J. Pattabiraman K. Pelkey E. T. Steinman L. Rothbard J. B. (2000). The Design, Synthesis, and Evaluation of Molecules that Enable or Enhance Cellular Uptake: Peptoid Molecular Transporters. Proc. Natl. Acad. Sci. 97, 13003–13008. 10.1073/pnas.97.24.13003 Wright E. R. Conticello V. P. (2002). Self-assembly of Block Copolymers Derived from Elastin-Mimetic Polypeptide Sequences. Adv. Drug Deliv. Rev. 54, 1057–1073. 10.1016/S0169-409X(02)00059-5 Wu H. Zhu L. Torchilin V. P. (2013). pH-sensitive Poly(histidine)-PEG/DSPE-PEG Co-polymer Micelles for Cytosolic Drug Delivery. Biomaterials 34, 1213–1222. 10.1016/j.biomaterials.2012.08.072 Wu J.-L. Tian G.-X. Yu W.-J. Jia G.-T. Sun T.-Y. Gao Z.-Q. (2016). pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin. Ijms 17, 364. 10.3390/ijms17040364 Xiao K. Luo J. Fowler W. L. Li Y. Lee J. S. Xing L. (2009). A Self-Assembling Nanoparticle for Paclitaxel Delivery in Ovarian Cancer. Biomaterials 30, 6006–6016. 10.1016/j.biomaterials.2009.07.015 Xu H. Yao Q. Cai C. Gou J. Zhang Y. Zhong H. (2015a). Amphiphilic Poly(amino Acid) Based Micelles Applied to Drug Delivery: The In Vitro and In Vivo Challenges and the Corresponding Potential Strategies. J. Controlled Release 199, 84–97. 10.1016/j.jconrel.2014.12.012 Xu W. Fan X. Zhao Y. Li L. (2015b). Cysteine Modified and Bile Salt Based Micelles: Preparation and Application as an Oral Delivery System for Paclitaxel. Colloids Surf. B: Biointerfaces 128, 165–171. 10.1016/j.colsurfb.2015.02.031 Yao C. Liu J. Wu X. Tai Z. Gao Y. Zhu Q. (2016). Reducible Self-Assembling Cationic Polypeptide-Based Micelles Mediate Co-delivery of Doxorubicin and microRNA-34a for Androgen-independent Prostate Cancer Therapy. J. Controlled Release 232, 203–214. 10.1016/j.jconrel.2016.04.034 Yeh J.-C. Yang H.-H. Hsu Y.-T. Su C.-M. Lee T.-H. Lou S.-L. (2013). Synthesis and Characteristics of Biodegradable and Temperature Responsive Polymeric Micelles Based on Poly(aspartic Acid)-G-poly(N-Isopropylacrylamide-Co-N,n-Dimethylacrylamide). Colloids Surf. A: Physicochemical Eng. Aspects 421, 1–8. 10.1016/j.colsurfa.2012.12.014 Yin L. Bao Y. Liu L. Wang J. Chen L. (2020). Acid‐sensitive Reactive Oxygen Species Triggered Dual‐drug Delivery Systems for Chemo‐photodynamic Therapy to Overcome Multidrug Resistance. Polym. Int. 69, 619–626. 10.1002/pi.5997 Zhai S. Hu X. Ji Z. Qin H. Wang Z. Hu Y. (2019). Pulsed Microwave-Pumped Drug-free Thermoacoustic Therapy by Highly Biocompatible and Safe Metabolic Polyarginine Probes. Nano Lett. 19, 1728–1735. 10.1021/acs.nanolett.8b04723 Zhang H. Wang K. Zhang P. He W. Song A. Luan Y. (2016). Redox-Sensitive Micelles Assembled From Amphiphilic mPEG-PCL-SS-DTX Conjugates for the Delivery of Docetaxel. Colloids Surf. B. Biointerfaces 142, 89–97. 10.1016/j.colsurfb.2016.02.045 Zhang M. Chen X. Li C. Shen X. (2020). Charge-reversal Nanocarriers: An Emerging Paradigm for Smart Cancer Nanomedicine. J. Controlled Release 319, 46–62. 10.1016/j.jconrel.2019.12.024 Zheng C. Zheng M. Gong P. Deng J. Yi H. Zhang P. (2013). Polypeptide Cationic Micelles Mediated Co-delivery of Docetaxel and siRNA for Synergistic Tumor Therapy. Biomaterials 34, 3431–3438. 10.1016/j.biomaterials.2013.01.053 Zheng P. Liu Y. Chen J. Xu W. Li G. Ding J. (2020). Targeted pH-Responsive Polyion Complex Micelle for Controlled Intracellular Drug Delivery. Chin. Chem. Lett. 31, 1178–1182. 10.1016/j.cclet.2019.12.001